Friday, July 17, 2009 | 1:30 p.m.
- Complete UFC 100 coverage
- Brock Lesnar: Can anyone beat this man?
- St. Pierre dominant despite injury
- UFC co-owner addresses fans at Expo
- Love story leads to UFC
- Lesnar wins, puts on WWE-style show afterward
- Win or lose — Mir a class act
- 702.tv: All-In: UFC 100
- Punchy Points: Key aspects about UFC 100
- Interactive Timeline: UFC Countdown: 1 to 100
The 13 fighters who were selected for drug testing at last weekend's UFC 100 all passed their tests according to Nevada State Athletic Commission Executive Director Keith Kizer.
All four headliners in the two title fights, Brock Lesnar and Frank Mir, and Georges St. Pierre and Thiago Alves, were tested for abusive drugs, like marijuana and cocaine, as well as anabolic steroids and other performance-enhancers. Yoshihiro Akiyama, Mark Coleman, Jon Fitch, Shannon Gugerty, Dan Henderson, Jon Jones, Dong Hyun Kim, Tom Lawlor and Jim Miller were also tested.
Some 13 fighters were also issued mandatory medical suspensions from the historic event that drew 11,000 fans for an estimated $5.1 million gate, which ranks as the second largest in UFC history.
Mir is suspended until Sept. 10 with no contact until Aug. 26 for precautionary reasons, while St. Pierre must have his groin injury cleared by an orthopedic doctor. The welterweight champ is suspended until Jan. 8, with no contact until Aug. 2 for precautionary reasons. Alves is suspended until Aug. 11 with no contact until Aug. 2 while "The Ultimate Fighter" coach Michael Bisping is suspended until Sept. 10 with no contact until Aug. 26 for precautionary reasons.
Akiyama has to have an orbital fractured cleared by an ophthalmologist. Mac Danzig is suspended until Sept. 10 with no contact until Aug. 26 due to a head laceration, Jim Miller must have right shoulder and clavicle X-rayed and cleared by a doctor and Gugerty must have lower back pain cleared by a doctor.
Stephan Bonnar, C.B. Dollaway, T.J. Grant, Matt Grice, and Jake O'Brien were all suspended for precautionary reasons.